FENNEC PHARMACEUTICALS INC shareholders Q3 2023

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.6%.

FENNEC PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHUMBLINE ADVISERS 20,547$154,2990.00%
VANGUARD GROUP INC 81,768$614,0780.00%
ROYAL BANK OF CANADA 5,866$43,0000.00%
BARCLAYS PLC 3,460$260.00%
BNP PARIBAS FINANCIAL MARKETS 16,515$124,0280.00%
OSAIC HOLDINGS, INC. 110$8260.00%
FMR LLC 422$3,1690.00%
AMERICAN INTERNATIONAL GROUP, INC. 9,057$68,0180.00%
BANK OF AMERICA CORP /DE/ 31,737$238,3450.00%
Russell Investments Group, Ltd. 321$2,4110.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,003$7,5330.00%
WELLS FARGO & COMPANY/MN 4,136$31,0610.00%
NORTHERN TRUST CORP 110,863$832,5810.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Legal & General Group Plc 1,494$11,1900.00%
GEODE CAPITAL MANAGEMENT, LLC 206,199$1,548,5540.00%
STATE STREET CORP 261,434$1,963,3690.00%
NEW YORK STATE COMMON RETIREMENT FUND 10,791$810.00%
JPMORGAN CHASE & CO 11,833$88,8660.00%
TORONTO DOMINION BANK 65$4880.00%
External links

This page lists FENNEC PHARMACEUTICALS INC's shareholders in Q3 2023. To view FENNEC PHARMACEUTICALS INC's shareholder history, click here.